The study aimed to prevent new basal cell carcinomas on the face and assess the safety of a topical treatment for adults with Gorlin syndrome.
Hightower’s previous clinical study focused on improving care for Gorlin syndrome by aiming to prevent recurring basal cell carcinomas and promote long-term skin health.
Gorlin syndrome, or nevoid basal cell carcinoma syndrome, is a genetic condition that affects multiple parts of the body and increases the risk of both cancerous and noncancerous tumors. The most common cancer seen in this condition is basal cell carcinoma, a type of skin cancer that often begins to appear in adolescence or early adulthood.
To support patients with Gorlin syndrome, Hightower Clinical conducted a study to evaluate the safety and effectiveness of a topical treatment aimed at preventing new basal cell carcinomas from developing on the face of affected adults.
Hightower Clinical conducted a study to support individuals with Gorlin syndrome by evaluating the safety and effectiveness of a topical treatment to prevent new facial basal cell carcinomas. This effort aimed to improve long-term skin health and reduce the recurrence of skin cancer in affected adults.
Not Recruiting
01
Study Name | Protocol Number | Sponsor |
---|---|---|
Gorlin Syndrome | SGT610-01 | Sol-Gel Technologies |
The study aimed to prevent new basal cell carcinomas on the face and assess the safety of a topical treatment for adults with Gorlin syndrome.
Adults diagnosed with Gorlin syndrome who were at risk of developing facial basal cell carcinomas.
No, the study is not recruiting at this time.